[1]Lim LP, Glasner ME, Yekta S, et al. Vertebrate microRNA genes [J]. Science, 2003, 299(5612):1540.
[2]Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004, 116(2):281-297.
[3]Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer [J]. Nat Revi Cancer, 2006, 6(4): 259-269.
[4]Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21- induced pre-B-cell lymphoma [J]. Nature, 2010, 467(7311): 86-90.
[5]Esau CC, Monia BP. Therapeutic potential for microRNAs [J]. Adva Drug Deliv Rev, 2007, 59(2-3): 101-114.
[6]Brown BD, Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications [J]. Nat Rev Genet, 2009, 10(8): 578-585.
[7]Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells [J]. Nat Methods, 2007, 4(9): 721-726.
[8]Ebert MS, Sharp PA. Emerging roles for natural MicroRNA sponges [J]. Curr Biol, 2010, 20(19): 858–861.
[9]Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities[J]. RNA, 2010, 16(11): 2043-2050.
[10]Gentner B, Schira G, Giustacchini A, et al. Stable knockdown of microRNA in vivo by lentiviral vectors[J]. Nat Methods, 2009, 6(1):63-66.
[11]Indraccolo S, Habeler W, Tisato V, et al. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentivial vectors [J]. Cancer Res, 2002, 62(21): 6099-6107.
[12]Han HB, Zhao W, Zhang ZhQ. Establishment of tetracycline-induced gene expression system based on the lentiviral vector [J]. Acta Anatomica sinica, 2011, 42(6): 756-760. (in Chinese)
韩海勃,赵威,张志谦. Tet-on慢病毒调控系统的构建及其调控作用 [J]. 解剖学报, 2011, 42(6): 756-760.
[13]Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span [J]. Curr Biol, 1998, 8(5): 279-282.
[14]Poole JC, Andrews LG, Tollefsbol TO, et al. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT) [J]. Gene, 2001, 269(1-2): 1-12.
[15]Fei J, Lan F, Guo M, et al. Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth [J]. J Drug Targeting, 2008, 16(9):688-693.
[16]Frankel LB, Christoffersen NR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells [J]. J Biolog Chemi, 2008, 283(2): 1026-1033.
[17]Si ML, Zhu S, Wu H, et al. miR-21-mediated tumor growth [J]. Oncogene, 2007, 26(19): 2799-2803.
[18]Bartel DP. MicroRNAs: target recognition and regulatory functions [J]. Cell, 2009, 136(2): 215-233.
[19]Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets [J]. Cell, 2005, 120(1):15-20.
[20]Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung [J]. Nature, 2005, 436(7050):518-524.
[21]Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC [J]. Nature, 2000, 406(6795):532-535. |